Plauth M, Raible A, Vieillard-Baron D, Bauder-Gross D, Hartmann F
Medizinische Klinik mit Schwerpunkt Gastroenterologie Hepatologie und Endokrinologie, Humboldt-Universität Berlin, Germany.
Int J Colorectal Dis. 1999 Apr;14(2):86-94. doi: 10.1007/s003840050191.
Glutamine has received considerable interest as a gut-targeted nutrient due to its proposed key role in the maintenance of intestinal structure and function. We used a preparation of isolated vascularly perfused rat small intestine to investigate whether glutamine is essential for the maintenance of intestinal function. When glutamine was available, arterial glutamine was extracted at 15 +/- 2%, and net uptake was -89 +/- 5 nmol min-1 g-1. Nitrogenous metabolites ammonia, alanine, and citrulline (41 +/- 7, 41 +/- 4, and 11 +/- 2 nmol min-1 g-1, respectively) were released into the venous perfusate, but only ammonia was also excreted into the lumen (36 +/- 3 nmol min-1 g-1). In the absence of exogenous glutamine alanine release was halved and that of citrulline and ammonia nullified. Additional inhibition of glutamine synthetase yielded the same results. In all cases variables of tissue function were fully maintained also in the absence of exogenous and/or endogenous glutamine. The inhibition of glutaminase/amidotransferase reactions, however, was accompanied by a reduction in glutamine consumption and a graded deterioration in tissue function. In conclusion, glutamine seems to be dispensable as a metabolic fuel to be fully oxidized by the mucosa. However, the inhibition of major glutamine consuming pathways was associated with impaired tissue function and viability. Therefore the role of intestinal glutamine metabolism seems to be threefold: (a) providing affluent amounts of nitrogen precursors for mucosal anabolic pathways to maintain intestinal structure and function, (b) feeding the liver with an optimal substrate mix, and (c) providing citrulline and thereby arginine for the whole organism.
谷氨酰胺作为一种针对肠道的营养物质受到了广泛关注,因为它在维持肠道结构和功能方面被认为起着关键作用。我们使用离体血管灌注大鼠小肠制剂来研究谷氨酰胺对于维持肠道功能是否必不可少。当有谷氨酰胺时,动脉谷氨酰胺的提取率为15±2%,净摄取量为-89±5 nmol·min⁻¹·g⁻¹。含氮代谢产物氨、丙氨酸和瓜氨酸(分别为41±7、41±4和11±2 nmol·min⁻¹·g⁻¹)被释放到静脉灌注液中,但只有氨也排泄到肠腔中(36±3 nmol·min⁻¹·g⁻¹)。在没有外源性谷氨酰胺的情况下,丙氨酸的释放量减半,瓜氨酸和氨的释放量则变为零。谷氨酰胺合成酶的进一步抑制产生了相同的结果。在所有情况下,即使没有外源性和/或内源性谷氨酰胺,组织功能变量也能完全维持。然而,谷氨酰胺酶/酰胺转移酶反应的抑制伴随着谷氨酰胺消耗的减少和组织功能的逐步恶化。总之,谷氨酰胺似乎并非黏膜完全氧化所需的代谢燃料。然而,主要谷氨酰胺消耗途径的抑制与组织功能和活力受损有关。因此,肠道谷氨酰胺代谢的作用似乎有三个方面:(a)为黏膜合成代谢途径提供大量氮前体以维持肠道结构和功能,(b)为肝脏提供最佳底物组合,(c)为整个机体提供瓜氨酸从而提供精氨酸。